UB Paderborn / Katalog / Suche / in CDI

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

The lancet oncology, 2014, Vol.15 (1), p.59-68

2014

Link zum Volltext

Verfügbarkeit prüfen

Neurobiological mechanisms involved in nicotine dependence and reward: Participation of the endogenous opioid system

Neuroscience and biobehavioral reviews, 2010-11, Vol.35 (2), p.220-231

2010

Link zum Volltext

Verfügbarkeit prüfen

464 2SMALL (NCT04253145) phase I part: lurbinectidine (LUR) in combination with atezolizumab (ATZ) for second line extensive stage small cell lung cancer (ES-SCLC) patients (pts)

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A493-A493

2021

Link zum Volltext

Verfügbarkeit prüfen

Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)

The lancet oncology, 2010-04, Vol.11 (4), p.350-357

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Clinical Staging According to TNM in Patients With SCLC: A Real-World Surveillance Epidemiology and End-Results Database Analysis

JTO clinical and research reports, 2022-01, Vol.3 (1), p.100266-100266, Article 100266

2022

Link zum Volltext

Verfügbarkeit prüfen

Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours

European journal of cancer (1990), 2023-10, Vol.192, p.113259-113259, Article 113259

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations

Lung cancer (Amsterdam, Netherlands), 2021-12, Vol.162, p.154-161

2021

Link zum Volltext

Verfügbarkeit prüfen

Attenuated behavioural responses to acute and chronic cocaine in GASP-1-deficient mice

The European journal of neuroscience, 2009-09, Vol.30 (5), p.860-868

2009

Link zum Volltext

Verfügbarkeit prüfen

The endogenous opioid system: A common substrate in drug addiction

Drug and alcohol dependence, 2010-05, Vol.108 (3), p.183-194

2010

Link zum Volltext

Verfügbarkeit prüfen

MDMA reinstates cocaine-seeking behaviour in mice

European neuropsychopharmacology, 2009-06, Vol.19 (6), p.391-397

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance

Lung cancer (Amsterdam, Netherlands), 2019-08, Vol.134, p.72-78

2019

Link zum Volltext

Verfügbarkeit prüfen

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

European journal of endocrinology, 2017-10, Vol.177 (4), p.309

2017

Link zum Volltext

Verfügbarkeit prüfen

Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis

Oncology and therapy, 2022-06, Vol.10 (1), p.167-184

2022

Link zum Volltext

Verfügbarkeit prüfen

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers

Cancer chemotherapy and pharmacology, 2022-04, Vol.89 (4), p.499-514

2022

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5407-5415

2008

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter Phase II Trial of ZD6474, a Vascular Endothelial Growth Factor Receptor-2 and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Previously Treated Metastatic Breast Cancer

Clinical cancer research, 2005-05, Vol.11 (9), p.3369-3376

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients

Archivos de bronconeumología (English ed.), 2024-02, Vol.60 (2), p.88-94

2024

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study

Oncotarget, 2017-09, Vol.8 (42), p.73144-73153

2017

Link zum Volltext

Verfügbarkeit prüfen

Are there differences by sex in lung cancer characteristics at diagnosis? —a nationwide study

Translational lung cancer research, 2021-10, Vol.10 (10), p.3902-3911

2021

Link zum Volltext

Verfügbarkeit prüfen

3,4-Methylenedioxymethamphetamine Self-Administration is Abolished in Serotonin Transporter Knockout Mice

Biological psychiatry (1969), 2007-09, Vol.62 (6), p.669-679

2007

Link zum Volltext

Verfügbarkeit prüfen

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

Cancer medicine (Malden, MA), 2021-09, Vol.10 (17), p.5878-5888

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I Clinical and Pharmacokinetic Study of Kahalalide F Administered Weekly as a 1-Hour Infusion to Patients with Advanced Solid Tumors

Clinical cancer research, 2008-02, Vol.14 (4), p.1116-1123

2008

Link zum Volltext

Verfügbarkeit prüfen

MDMA modifies active avoidance learning and recall in mice

Psychopharmacologia, 2008-04, Vol.197 (3), p.391-400

2008

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Neurobiological mechanisms involved in nicotine dependence and reward: Participation of the endogenous opioid system

Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics

464 2SMALL (NCT04253145) phase I part: lurbinectidine (LUR) in combination with atezolizumab (ATZ) for second line extensive stage small cell lung cancer (ES-SCLC) patients (pts)

Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)

Prognostic Value of Clinical Staging According to TNM in Patients With SCLC: A Real-World Surveillance Epidemiology and End-Results Database Analysis

Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours

Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations

Attenuated behavioural responses to acute and chronic cocaine in GASP-1-deficient mice

The endogenous opioid system: A common substrate in drug addiction

MDMA reinstates cocaine-seeking behaviour in mice

Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

A Multicenter Phase II Trial of ZD6474, a Vascular Endothelial Growth Factor Receptor-2 and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Previously Treated Metastatic Breast Cancer

Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients

A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study

Are there differences by sex in lung cancer characteristics at diagnosis? —a nationwide study

3,4-Methylenedioxymethamphetamine Self-Administration is Abolished in Serotonin Transporter Knockout Mice

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

Phase I Clinical and Pharmacokinetic Study of Kahalalide F Administered Weekly as a 1-Hour Infusion to Patients with Advanced Solid Tumors

Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study

MDMA modifies active avoidance learning and recall in mice

Suchergebnisse filtern